BIO vs JCI · rev $651.0M vs P/E 44, rev $23.60B
BIO (BIO) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
BIO currently screens at market cap $0. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the BIO and JCI stock pages for the full models.
Not investment advice.